跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 39 条关于
“KDIGO”
全部
39
临床试验
11
药物
0
机构
0
资讯
28
上个月
Talphera's nafamostat gains KDIGO endorsement as NEPHRO CRRT trial nears completion
去年
Singapore Trial to Evaluate Multicomponent Intervention for Chronic Kidney Disease Management
11个月前
Climb Bio's CLYM116 Shows Superior Performance in IgA Nephropathy Preclinical Study
2年前
Travere Therapeutics' Filspari Receives Full FDA Approval for IgAN Treatment, Expanding Patient Access
去年
SGLT2 Inhibitors Show Promise in Managing Chronic Kidney Disease in Real-World Settings
去年
Arch Biopartners Initiates Phase II Trial of LSALT Peptide for Cardiac Surgery-Associated Acute Kidney Injury
去年
Arch Biopartners Doses First Canadian Subject in Phase II Trial of LSALT Peptide for Cardiac Surgery-Associated Acute Kidney Injury
10个月前
Renalytix's kidneyintelX.dkd Test Shows Superior CKD Risk Prediction in Major Diabetes Care Study
2年前
Arch Biopartners Receives Ethics Approval for Phase II Trial of LSALT Peptide in Calgary
去年
Arch Biopartners Initiates Phase II Trial of LSALT Peptide for Cardiac Surgery-Associated Acute Kidney Injury
第 1 页,共 3 页
上一页
下一页